Multidisciplinary international expert consensus recommendations on tissue acquisition in non-small cell lung cancer - PubMed
3 hours ago
- #NSCLC
- #Precision Medicine
- #Biopsy Techniques
- Precision medicine has improved outcomes for advanced non-small cell lung cancer (NSCLC) and is now being applied to early-stage NSCLC.
- There is significant variation in diagnostic yields and procedural complications, highlighting the need for a multidisciplinary consensus approach.
- An international expert panel from the US, Europe, and Asia-Pacific developed consensus recommendations through structured discussions and reviews.
- Biopsy should target the most advanced stage site, with technique choice depending on the tissue location (e.g., pulmonary nodules, lymph nodes, pleural disease).
- Optimal biopsy techniques should support diagnosis and staging, considering clinical presentation, diagnostic yield, sample type, invasiveness, and patient-centered care.
- Funding for the consensus was provided by AstraZeneca, and several authors disclosed conflicts of interest related to pharmaceutical companies.